Integrated Biopharma, Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue Integrated Biopharma, Inc. is now 14 197 000 $. Information about net revenue is taken from open sources. The dynamics of net revenue of Integrated Biopharma, Inc. rose. The change amounted to 2 791 000 $. The dynamics of net revenue is shown in comparison with the previous report. Net income Integrated Biopharma, Inc. - 959 000 $. Information about net income is used from open sources. Integrated Biopharma, Inc. online financial report chart. Integrated Biopharma, Inc. financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. Information on Integrated Biopharma, Inc. net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/12/2019
14 197 000 $
+18.3 % ↑
959 000 $
+289.84 % ↑
30/09/2019
11 406 000 $
+10.69 % ↑
312 000 $
+96.23 % ↑
30/06/2019
13 584 000 $
+8.11 % ↑
360 000 $
-55.99 % ↓
31/03/2019
14 088 000 $
-
923 000 $
-
31/12/2018
12 001 000 $
-
246 000 $
-
30/09/2018
10 304 000 $
-
159 000 $
-
30/06/2018
12 565 000 $
-
818 000 $
-
Show:
to
Integrated Biopharma, Inc. financial report charts
The dates of the latest financial statements of Integrated Biopharma, Inc.: 30/06/2018, 30/09/2019, 31/12/2019. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Integrated Biopharma, Inc. for today is 31/12/2019. Gross profit Integrated Biopharma, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Integrated Biopharma, Inc. is 2 026 000 $
Integrated Biopharma, Inc. quarterly report dates
Cost of revenue Integrated Biopharma, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Integrated Biopharma, Inc. is 12 171 000 $ Total revenue Integrated Biopharma, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Integrated Biopharma, Inc. is 14 197 000 $ Operating revenue Integrated Biopharma, Inc. is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides. Operating revenue Integrated Biopharma, Inc. is 14 197 000 $
Operating income Integrated Biopharma, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Integrated Biopharma, Inc. is 1 205 000 $ Net income Integrated Biopharma, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Integrated Biopharma, Inc. is 959 000 $ Current assets Integrated Biopharma, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Integrated Biopharma, Inc. is 14 536 000 $
31/12/2019
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 026 000 $
1 399 000 $
1 579 000 $
2 093 000 $
1 330 000 $
1 219 000 $
1 466 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
12 171 000 $
10 007 000 $
12 005 000 $
11 995 000 $
10 671 000 $
9 085 000 $
11 099 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
14 197 000 $
11 406 000 $
13 584 000 $
14 088 000 $
12 001 000 $
10 304 000 $
12 565 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
14 197 000 $
11 406 000 $
13 584 000 $
14 088 000 $
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 205 000 $
476 000 $
574 000 $
1 237 000 $
487 000 $
405 000 $
625 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
959 000 $
312 000 $
360 000 $
923 000 $
246 000 $
159 000 $
818 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
-
-
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
12 992 000 $
10 930 000 $
13 010 000 $
12 851 000 $
11 514 000 $
9 899 000 $
11 940 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
14 536 000 $
14 083 000 $
14 079 000 $
16 350 000 $
16 540 000 $
13 733 000 $
12 154 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
19 971 000 $
19 641 000 $
19 790 000 $
22 221 000 $
22 575 000 $
19 724 000 $
14 568 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
67 000 $
525 000 $
475 000 $
431 000 $
45 000 $
365 000 $
228 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
12 293 000 $
12 542 000 $
12 353 000 $
14 437 000 $
15 511 000 $
12 576 000 $
16 180 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
16 777 000 $
17 421 000 $
17 897 000 $
20 832 000 $
22 109 000 $
19 529 000 $
19 804 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
84.01 %
88.70 %
90.43 %
93.75 %
97.94 %
99.01 %
135.94 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
3 194 000 $
2 220 000 $
1 893 000 $
1 389 000 $
466 000 $
195 000 $
-5 236 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-627 000 $
1 685 000 $
627 000 $
615 000 $
-1 507 000 $
593 000 $
-175 000 $
Last revenue report of Integrated Biopharma, Inc. was 31/12/2019. According to last financial report total revenue in Integrated Biopharma, Inc. was 14 197 000 US dollar and changed by +18.3% since last year. Net income in Integrated Biopharma, Inc. was 959 000 $ in last quartal, net income changes to +289.84%.
Total assets Integrated Biopharma, Inc. refers to the total amount of assets owned by a person or entity. Total assets Integrated Biopharma, Inc. is 19 971 000 $ Current cash Integrated Biopharma, Inc. - the sum of all of the cash a company has on the date of report. Current cash Integrated Biopharma, Inc. is 67 000 $ Current debt Integrated Biopharma, Inc. is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital. Current debt Integrated Biopharma, Inc. is 12 293 000 $
Integrated Biopharma, Inc. stocks data
INBP stock price
Integrated Biopharma, Inc. stock price today, INBP stock quote.
